Plasma metalloproteinase activity is enhanced in the euglobulin fraction of breast and lung cancer patients

International Journal of Cancer

Volumn 89, Issue 4, 2000, Pages 389-394

  Farias, Eduardo ^a   Ranuncolo, Stella ^a   Cresta, Carlos ^b   Specterman, Sergio ^c   Armanasco, Eduardo ^b   Varela, Mirta ^c   Lastiri, José ^c   Pallotta, María Guadalupe ^c   De Kier Joffe, Elisa Bal ^a   Puricelli, Lydia ^a,b  

^a Clinical Research Area   (Argentina)

^b Instituto de Oncologia Angel H Roffo   (Argentina)

^c HOSPITAL ITALIANO DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

GLOBULIN; MATRIX METALLOPROTEINASE; TUMOR MARKER;

ADULT; AGED; ARTICLE; BRAIN TUMOR; BREAST CANCER; CANCER INVASION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ASTROCYTOMA; BRAIN NEOPLASMS; BREAST NEOPLASMS; COLONIC NEOPLASMS; FEMALE; GLIOBLASTOMA; HUMANS; LUNG NEOPLASMS; MALE; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; SERUM GLOBULINS; TUMOR MARKERS, BIOLOGICAL;

EID: 0034691580     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000720)89:4<389::AID-IJC12>3.0.CO;2-J     Document Type: Article

References (33)

1. ALONSO, D.F., FARÍAS, E.F. and BAL DE KIER JOFFÉ, E.D., Impairment of fibrinolysis during the growth of two murine mammary adenocarcinomas. Cancer Lett., 70, 181-118 (1993).
2. BOYER, M.J. and TANNOCK, I.F., Lysosomes, lysosomal enzymes and cancer. Adv. Cancer Res., 60, 269-291 (1993).
3. DAVIES, B., MILES, D.W., HAPPERFIELD, L.C., NAYLOR, M.S., BOBROW, L.G., RUBENS, R.D. and BALKWILL, F.R., Activity of type IV collagenases in benign and malignant breast disease. Brit. J. Cancer, 67,1126-1131 (1993a).
4. DAVIES, B., WAXMAN, J., HARPREST, W., ABEL, P., WILLIAMS, G., KRAUSZ, T. ET AL., Levels of matrix metalloproteases in bladder cancer correlate with tumor grade and invasion. Cancer Res., 53, 5365-5369 (1993b).
5. DECLERCK, Y.A., IMREN, S., MONTGOMERY, A.M., MUELLER, B.M., REISFELD, R.A. and LAUG, W.E., Protease and protease inhibitors in tumor progression. Adv. Exp. med. Biol., 425, 89-97 (1997).
6. DUFFY, M.J., BLASER, J., DUGGAN, C., MCDERMOTT, E., HIGGINS, N.O., FENNELLY, J.J. and TSCHESCHE, H., Assay of matrix metalloproteinases types 8 and 9 by ELISA in human breast cancer. Brit. J. Cancer, 71, 1025-1028 (1995).
7. DUFFY, M.J. and MCCARTHY, K., Matrix metalloproteinases in cancer: prognostic markers and targets for therapy. Int. J. Oncol., 12, 1343-1348 (1998).
8. FLETCHER, R.H., FLETCHER, S.W. and WAGNER, E.H. (EDS.), Clinical epidemiology. The essentials, 2nd ed., Williams and Wilkins, Baltimore (1988).
9. GARBISA, S., SCAGLIOTTI, G., MASIERO, L., DI FRANCESCO, C., CAENAZZO, C., ONISTO, M. ET AL., Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy. Cancer Res., 52, 4548-4549 (1992).
10. GARZETTI, G.G., CIAVATTINI, A., LUCARINI, G., GOTERI, G., ROMANINI, C. and BIAGINI, G., Increased serum 72 kDa metalloproteinase in serous ovarian tumors: comparison with CA 125. Anticancer Res., 16, 2123-2127 (1996).
11. GOMEZ, D.E., ALONSO, D.F., YOSHIJI, H. and THORGEIRSSON, U.P., Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Europ. J. cell Biol., 2, 111-122 (1997).
12. HASHIMOTO, N., IKOBAYASHI, M. and TSUJI, T., Serum type IV collagen-degrading enzyme in hepatocellular carcinoma with metastasis. Acta Med. Okayama, 42, 1-6 (1998).
13. HEUSSEN, C. and DOWLE, E.B., Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. Anal. Biochem., 102, 196-202 (1980).
14. ISIDORO, C., DÉMOZ, M., DE STEFANIS, D., BACCINO, F.M. and BONELLI, G., High levels of proteolytic enzymes in the ascitic fluid and plasma of rats bearing the Yoshida AH-130 hepatoma. Invasion Metastasis, 15, 116-124 (1995).
15. KATO, Y., NAKAYAMA, Y., UMEDA, M. and MIYAZAKI, K., Induction of 103 kDa gelatinase/type IV collagenase by acidic culture conditions in mouse metastatic melanoma cell lines. J. Biochem., 267, 11424-11430 (1992).
16. LAEMMLI, U., Cleavage of structural proteins during assembly of the head of bacteriophage. Nature (Lond.), 221, 680-689 (1970).
17. MACDOUGALL, J.R. and MATRISIAN, L.M., Contributions of tumor and stromal matrix metalloproteinases to tumor progression, invasion and metastasis. Cancer Metastasis Rev., 14, 351-362 (1995).
18. MONTEAGUDO, C., MERINO, M., SAN-JUAN, J., LIOTTA, L.A. and STETLER-STEVENSON, W.G., Immunohistological distribution of type IV collagenase in normal, benign and malignant breast tissue. Amer. J. Pathol., 136, 585-592 (1990).
19. MOSES, M.A., WIEDERSCHAIN, D., LOUGHLIN, K.R., ZURAKOWSKI, D., LAMB, C.C. and FREEMAN, M.R., Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res., 58, 1395-1399 (1998).
20. NAGASE, H., Activation mechanisms of matrix metalloproteinases. Biol. Chem., 378, 151-160 (1997).
21. NAKAJIMA, M., BERNHARD, E.J., MUSCEL, R.J. and HUGHES, E.N., Mr 92000 gelatinase release correlates with the metastatic phenotype in transformed rat embryo cells. Cancer Res., 50, 3872-3877 (1990).
22. NAKAJIMA, M., WELCH, D.R., WYNN, D.M., TSURO, T. and NICOLSON, G.L., Serum and plasma Mr 92000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. Cancer Res., 53, 5802-5807 (1993).
23. NICOLSON, G.L., Cancer metastasis: tumor cell and host organ properties important in metastasis to specific secondary sites. Biochem. biophys. Acta, 948, 175-224 (1988).
24. NOMURA, H., SATO, H., SEIKI, M., MAI, M. and OKADA, Y., Expression of membrane-type metalloproteinase in human gastric carcinomas. Cancer Res., 55, 3263-3266 (1995).
25. PITTMAN, R.N., Release of plasminogen activator and calcium dependent metalloproteinase from cultured sympathetic and sensory neurons. Develop. Biol., 110, 91-101 (1985).
26. PRICE, J.T., BONOVICH, M.T. and KOHN, E.C., The biochemistry of cancer dissemination. Crit. Rev. Biochem. mol. Biol., 32, 175-253 (1997).
27. SIER, C.F.M., KUBBEN, F.J.G.M., GANESH, S., HEERDING, M.M., GRIFFIOEN, G., HANEMAAIJER, R. ET AL., Tissue levels of matrix metalloproteinases MMP-2 and MMP-9 are related to the overall survival of patients with gastric carcinoma. Brit. J. Cancer, 74, 413-417 (1996).
28. STEARNS, M.E. and WANG, M., Type IV collagenase (Mr 72000) expression in human prostate: benign and malignant tissue. Cancer Res., 53, 878-883 (1993).
29. URBANSKY, S.J., EDWARDS, D.R., MAITLAND, A., LECO, K.J., WATSON, A. and KOSSAKOWSKA, A.E., Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas. Brit. J. Cancer, 66, 1188-1194 (1992).
30. VARTIO, T. and BAUMANN, M., Human gelatinase/type IV procollagenase is a regular plasma component. FEBS Lett., 255, 285-289 (1989).
31. ZUCKER, S., LYSIK, R.M., DIMASSIMO, B.I., ZARRABI, H.M., MOLL, U.M., GRIMSON, R. TICKLE, S., DOCHERTY, P., Plasma assay of gelatinase B: tissue inhibitor of metalloproteinase complexes in cancer. Cancer, 76, 700-708 (1995).
32. ZUCKER, S., LYSIK, R.M., ZARRABI, M.H. and MOLL, U., Mr 92000 type IV collagenase is increased in plasma of patients with colon and breast cancer. Cancer Res., 53, 140-146 (1993).
33. ZUCKER, S., LYSIK, R.M., ZARRABI, H.M., MOLL, U., TICKLE, S.P., STETLER-STEVENSON, BACKER, T.S., DOCHERTY, A.J., Plasma assay of matrix metalloproteinases (MMP) and MMP-inhibitor complexes in cancer. Ann. N. Y. Acad. Sci., 732, 248-262 (1994).